Novel drug shows early promise in treating multiple myeloma - EurekAlert
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania’s Abramson Cancer Center at the 2022 American Soci…
NEW ORLEANS – A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the Un… [+3767 chars]
Read More
Other Stories in Business
- Tesla (TSLA) Owners' Data Leak Raises Privacy Concerns
- Tesla (TSLA) Owners' Data Leak Raises Privacy Concerns
- Full Year 2024 Verimatrix SA Earnings Call Transcript
- Full Year 2024 Verimatrix SA Earnings Call Transcript
- Megint jött a Ryanair és küldött egy finom sallert a kormánynak
- 3 Things: Tariffs, Bear Markets And Inflation
- DOGE's anti-DEI drive flagged these programs. Only they weren't DEI.
- Fun and Immersive Experience awaits visitors
- Ray Dalio Cites 1930s Germany to Assess Unfolding Trade War
